Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of quality of life after bladder augmentation in patients previously treated with intradetrusor botulinum toxin A for neurogenic detrusor overactivity.
Bakali Issaui Z, Truong XQ, Genon M, Gaillet S, Tournebise H, Zini P, Bernuz B, Thiry Escudier I, Bardot P, Radot C, Muro C, Lenne Aurier K, Bonopera R, De Brier G, Boissier R, Lechevallier E, Karsenty G, Michel F. Bakali Issaui Z, et al. Among authors: tournebise h. Fr J Urol. 2024 Nov;34(10):102706. doi: 10.1016/j.fjurol.2024.102706. Epub 2024 Jul 24. Fr J Urol. 2024. PMID: 39059768
Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study.
Michel F, Ciceron C, Bernuz B, Boissier R, Gaillet S, Even A, Chartier-Kastler E, Denys P, Gamé X, Ruffion A, Normand LL, Perrouin-Verbe B, Saussine C, Manunta A, Forin V, De Seze M, Grise P, Tournebise H, Schurch B, Karsenty G. Michel F, et al. Among authors: tournebise h. Urology. 2019 Jul;129:43-47. doi: 10.1016/j.urology.2019.03.010. Epub 2019 Mar 26. Urology. 2019. PMID: 30926380
Résultats du changement de marque de toxine botulinique de type A (TBA), Botox(®) vers Dysport(®), dans le traitement de l'hyperactivité détrusorienne neurogène (HDN).
Bottet F, Peyronnet B, Game X, Manunta A, Ruffion A, Perrouin-Verbe B, Reiss B, Previnaire J, Tournebise H, Bernuz B, Lenne K, Lechevallier E, Karsenty G. Bottet F, et al. Among authors: tournebise h. Prog Urol. 2015 Nov;25(13):737. doi: 10.1016/j.purol.2015.08.043. Prog Urol. 2015. PMID: 26544238 French. No abstract available.
[Intensive care ... and after?].
Boucand MH, Tournebise H. Boucand MH, et al. Among authors: tournebise h. Agressologie. 1990;31(10):725-6. Agressologie. 1990. PMID: 2099643 French.
[Hyperparathyroidism induced by lithium. A new case].
Pieri-Balandraud N, Hugueny P, Henry JF, Tournebise H, Dupont C. Pieri-Balandraud N, et al. Among authors: tournebise h. Rev Med Interne. 2001 May;22(5):460-4. doi: 10.1016/s0248-8663(01)00371-x. Rev Med Interne. 2001. PMID: 11402517 French.
Paraplegia and decompression sickness.
Tournebise H, Boucand MH, Landi J, Theobald X. Tournebise H, et al. Paraplegia. 1995 Nov;33(11):636-9. doi: 10.1038/sc.1995.134. Paraplegia. 1995. PMID: 8584297
French cross-cultural adaptation and validity of the Moorong Self-Efficacy scale: the MSES-FR, a measure of Self-Efficacy for French people with spinal cord injury.
Gounelle M, Cousson-Gelie F, Nicolas B, Kerdraon J, Gault D, Tournebise H, Goossens D, Leynaert V, Middleton J, Coffy A, Gelis A. Gounelle M, et al. Among authors: tournebise h. Disabil Rehabil. 2022 Dec;44(25):8066-8074. doi: 10.1080/09638288.2021.2003452. Epub 2021 Nov 22. Disabil Rehabil. 2022. PMID: 34802337
14 results